Accolade price target lowered to $11 from $13 at Barclays

Barclays lowered the firm’s price target on Accolade to $11 from $13 and keeps an Equal Weight rating on the shares. The stock sold off post earnings on a guidance miss and wider than expected fiscal 2025 revenue range, which overshadowed a headline beat and the company’s recent profitability strides, the analyst tells investors in a research note. The firm believes the guidance embeds healthy conservatism that could position Accolade for future beats.